Page last updated: 2024-11-08
3-ketosucrose
Description
3-ketosucrose: intermediate in production of 3-amino-3-deoxysucrose; RN given refers to (alpha-D-hexopyranoside & beta-D-fructofuranose)-isomers; RN for cpd without isomeric designation not available 7/89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
3-ketosucrose : A glycosyl glycoside which is an intermediate in the breakdown of sucrose. The structure is that of sucrose in which the glucosyl 3-hydroxy group has been reduced to a keto group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 440773 |
| CHEBI ID | 17429 |
| MeSH ID | M0166631 |
Synonyms (15)
| Synonym |
|---|
| alpha-d-ribo-hexopyranosid-3-ulose, beta-d-fructofuranosyl |
| 3-oxosucrose |
| 3-dehydro-alpha-d-glucosyl beta-d-fructofuranoside |
| beta-d-fructofuranosyl alpha-d-ribo-hexopyranosid-3-ulose |
| CHEBI:17429 , |
| 3'-ketosucrose |
| C05731 , |
| 1883-12-1 |
| 3-dehydro-alpha-d-glucosyl-beta-d-fructofuranoside |
| 3-ketosucrose |
| alpha-d-ribo-hexopyranosyl-3-ulose-beta-d-fructofuranoside |
| 3'-dehydro-alpha-d-glucosyl-beta-d-fructofuranoside |
| (2r,3s,5r,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-one |
| DTXSID80172178 |
| Q27102396 |
Drug Classes (2)
| Class | Description |
|---|
| keto-disaccharide | Any disaccharide that contains a keto group within its structure. |
| glycosyl glycoside | Any disaccharide in which the two monosaccharide components are connected by a glycosidic linkage between their anomeric centres. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.46
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.46 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.25 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |